Cyclophosphamide and dimethylsulfoxide in the treatment of squamous carcinoma of the lung therapeutic efficacy, toxicity and pharmacokinetics

مهمان عزیز شما حق دیدن لینک ها را ندارید برای استفاده از امکانات کامل انجمن عضو شوید

عضویت

Thus, although IP is a rare adverse event among breast cancer patients, its risk is substantially higher than that in the general population